During the past decade, Centre Hospitalier de Mouscron conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Mouscron" #1 sponsor was "Shire" with 9 trials, followed by "Celgene" with 1 trials sponsored, "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "University Ghent" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Mouscron" #1 collaborator was "BUPA Foundation" with 1 trials as a collaborator, "Ferring Pharmaceuticals" with 1 trials as a collaborator, "NHS Health Technology Assessment Programme" with 1 trials as a collaborator and "University Hospital, Geneva" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Mouscron" are "Crohn's Disease" (6 trials), "Ulcerative Colitis" (5 trials), "Prostate Cancer" (2 trials), "Carotid Stenosis" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Centre Hospitalier de Mouscron" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Mouscron" are "Drug" (11 trials), "Other" (3 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ontamalimab" (4 trials), "225mg SHP647 (PF-00547659)" (1 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Mouscron" are 12 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Mouscron". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centre Hospitalier de Mouscron, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Mouscron, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Centre Hospitalier de Mouscron has several departments that took part in Clinical trials: "Department of Pneumology Centre Hospitalier de Mouscron" - 5 trials